
Opinion|Videos|May 16, 2025
Strategies to Minimize Toxicities, and the Pharmacist’s Role in Educating and Supporting Patients With NSCLC
Author(s)Lauren Ledbetter, PharmD, BCOP
A panelist discusses how to minimize EGFR tyrosine kinase inhibitor (TKI) adverse effects through preventive measures such as maintaining good skin regimens with moisturizers and SPF 30+ sunscreen, prescribing topical steroids and antibiotics for skin rash, and managing diarrhea with hydration, diet modifications, and loperamide.
Advertisement
Episodes in this series

Management Strategies for EGFR TKI Adverse Effects: Summary for Physicians
Dermatologic Toxicity Management
- Proactive skin care regimen before initiating EGFR TKIs:
- Recommend non–alcohol-based creamy moisturizers (morning and night)
- Daily SPF 30+ sunscreen on exposed areas
- Encourage protective clothing (hats, long sleeves)
- Treatment options for acneiform rash:
- Topical steroids
- Topical clindamycin gel
- Oral doxycycline (helps reduce severity and prevent superimposed infection)
- Consider dermatology referral for severe cases
Diarrhea Management
- Patient education:
- Instruct patients to monitor and track stool frequency above baseline
- Emphasize adequate hydration
- Dietary modifications:
- Recommend BRAT-style diet (bananas, rice, apples, toast)
- Low-fiber, bland foods
- Avoid dairy, greasy, and fatty foods
- Pharmacologic intervention:
- Provide step-by-step loperamide (Imodium) dosing instructions
- Review medication list for potential exacerbating agents
- Instruct patients to hold laxatives/stool softeners during diarrhea episodes
Clinical Pearls
- Male patients may require additional encouragement regarding skin care regimens
- Emphasize importance of patient communication between visits
- Always perform medication reconciliation to identify potential contributory medications
- Ensure patients have clear instructions for all prescribed treatments
This approach focuses on proactive management to minimize adverse events while maintaining treatment efficacy.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Updated Guidelines Reflect Advances in CKD Management
2
GLP-1 Agonists as Therapeutics for Alzheimer's Disease: Not Right Now, but Maybe in the Future
3
Study: Pharmacists, Female Pharmacy Technicians at a Higher Risk of Suicide Than General Population
4
FDA Accepts sBLA for IV Efgartigimod to Treat Patients With AChR-Ab Seronegative gMG
5














































































































































































































